CDH1 and breast carcinoma: These results could not be explained by the function of alternative integrin ligands on E0771 breast cancer cells such as VCAM-1 (a VLA-4 ligand) or E-cadherin, a CD103 ligand expressed by certain solid tumor cells (65).